Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 32974 | 131 | 32.0 | 64% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
| 519 | 3 | BLOOD SUBSTITUTES//NEUROGLOBIN//HEMOGLOBIN | 20769 |
| 2593 | 2 | BLOOD SUBSTITUTES//ARTIFICIAL CELLS BLOOD SUBSTITUTES AND BIOTECHNOLOGY//HEMOGLOBIN BASED OXYGEN CARRIER | 3632 |
| 32974 | 1 | LIPOPROTEIN FRACTIONS AND SUBFRACTIONS//TRITON WR 1339 INDUCED HYPERLIPIDEMIC RATS//POLOXAMER 407 | 131 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | LIPOPROTEIN FRACTIONS AND SUBFRACTIONS | authKW | 1165480 | 4% | 100% | 5 |
| 2 | TRITON WR 1339 INDUCED HYPERLIPIDEMIC RATS | authKW | 932384 | 3% | 100% | 4 |
| 3 | POLOXAMER 407 | authKW | 475376 | 15% | 11% | 19 |
| 4 | 5 FLUORO N 9 10 DIHYDRO 9 10 DIOXOANTHRACEN 8 YL 1H INDOLE 2 CARBOXAMIDES | authKW | 233096 | 1% | 100% | 1 |
| 5 | ANTIHYPERGLYCERIDEMIA | authKW | 233096 | 1% | 100% | 1 |
| 6 | BASIC PLA MED | address | 233096 | 1% | 100% | 1 |
| 7 | BENZOFURAN 2 CARBOXAMIDE | authKW | 233096 | 1% | 100% | 1 |
| 8 | BENZOYLPHENYL 1H INDOLE 2 CARBOXAMIDES | authKW | 233096 | 1% | 100% | 1 |
| 9 | BIOL PLANT MICROORGANS | address | 233096 | 1% | 100% | 1 |
| 10 | BM12C N 4 BENZOYLPHENYL 5 METHOXY 1H INDOLE 2 CARBOXAMIDE | authKW | 233096 | 1% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Pharmacology & Pharmacy | 799 | 46% | 0% | 60 |
| 2 | Chemistry, Medicinal | 89 | 8% | 0% | 11 |
| 3 | Biochemistry & Molecular Biology | 49 | 20% | 0% | 26 |
| 4 | Cardiac & Cardiovascular System | 44 | 8% | 0% | 11 |
| 5 | Nutrition & Dietetics | 30 | 5% | 0% | 6 |
| 6 | CYTOLOGY & HISTOLOGY | 29 | 1% | 0% | 1 |
| 7 | Medicine, Research & Experimental | 23 | 6% | 0% | 8 |
| 8 | Physiology | 21 | 5% | 0% | 7 |
| 9 | Integrative & Complementary Medicine | 17 | 2% | 0% | 2 |
| 10 | Biology | 16 | 4% | 0% | 5 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | BASIC PLA MED | 233096 | 1% | 100% | 1 |
| 2 | BIOL PLANT MICROORGANS | 233096 | 1% | 100% | 1 |
| 3 | KATZ GRP PHARM HLTH 142H 2 | 233096 | 1% | 100% | 1 |
| 4 | PHYSIOL ERTHNOPHARMACOL | 233096 | 1% | 100% | 1 |
| 5 | VOROZHTZOV NN ORGAN CHEM | 233096 | 1% | 100% | 1 |
| 6 | WMU WU JOINT | 233096 | 1% | 100% | 1 |
| 7 | KATZ GRP PHARM HLTH 3 142H | 116547 | 1% | 50% | 1 |
| 8 | VOROZTZOV NN ORGAN CHEM | 116547 | 1% | 50% | 1 |
| 9 | OTC PROD | 77697 | 1% | 33% | 1 |
| 10 | PHYSIOL FUNDAMENTAL MED | 40535 | 2% | 9% | 2 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES | 12132 | 5% | 1% | 6 |
| 2 | BIOPHARMACEUTICS & DRUG DISPOSITION | 1931 | 3% | 0% | 4 |
| 3 | JOURNAL OF PHARMACY AND PHARMACOLOGY | 1421 | 5% | 0% | 7 |
| 4 | LIPIDS IN HEALTH AND DISEASE | 1385 | 2% | 0% | 3 |
| 5 | INTERNATIONAL JOURNAL OF PHARMACOLOGY | 1246 | 2% | 0% | 2 |
| 6 | ADVANCES IN INTERNAL MEDICINE | 1200 | 1% | 1% | 1 |
| 7 | JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY | 1075 | 2% | 0% | 3 |
| 8 | ZEITSCHRIFT FUR NATURFORSCHUNG SECTION C-A JOURNAL OF BIOSCIENCES | 772 | 3% | 0% | 4 |
| 9 | SCANDINAVIAN JOURNAL OF LABORATORY ANIMAL SCIENCE | 688 | 1% | 0% | 1 |
| 10 | CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY | 539 | 3% | 0% | 4 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | BIN JARDAN, YA , BROCKS, DR , (2016) THE PHARMACOKINETICS OF DRONEDARONE IN NORMOLIPIDEMIC AND HYPERLIPIDEMIC RATS.BIOPHARMACEUTICS & DRUG DISPOSITION. VOL. 37. ISSUE 6. P. 345 -351 | 11 | 52% | 0 |
| 2 | SHATTAT, G , AL-QIRIM, T , ABU SHEIKHA, G , AL-HIARI, Y , SWEIDAN, K , AL-QIRIM, R , HIKMAT, S , HAMADNEH, L , AL-KOUZ, S , (2013) THE PHARMACOLOGICAL EFFECTS OF NOVEL 5-FLUORO-N-(9,10-DIHYDRO-9,10-DIOXOANTHRACEN-8-YL)-1H-INDOLE-2-CARBOXAMIDE DERIVATIVES ON PLASMA LIPID PROFILE OF TRITON-WR-1339-INDUCED WISTAR RATS.JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. VOL. 28. ISSUE 4. P. 863-869 | 9 | 60% | 1 |
| 3 | TUZIKOV, FV , KOROLENKO, TA , JOHNSTON, TP , TUZIKOVA, NA , PUPYSHEV, AB , SPIRIDONOV, VK , GONCHAROVA, NV , MAIBORODIN, IV , ZHUKOVA, NA , (2016) EARLY-STAGE ATHEROSCLEROSIS IN POLOXAMER 407-INDUCED HYPERLIPIDEMIC MICE: PATHOLOGICAL FEATURES AND CHANGES IN THE LIPID COMPOSITION OF SERUM LIPOPROTEIN FRACTIONS AND SUBFRACTIONS.LIPIDS IN HEALTH AND DISEASE. VOL. 15. ISSUE . P. - | 11 | 34% | 1 |
| 4 | LEON, C , WASAN, KM , SACHS-BARRABLE, K , JOHNSTON, TP , (2006) ACUTE P-407 ADMINISTRATION TO MICE CAUSES HYPERCHOLESTEROLEMIA BY INDUCING CHOLESTEROLGENESIS AND DOWN-REGULATING LOW-DENSITY LIPOPROTEIN RECEPTOR EXPRESSION.PHARMACEUTICAL RESEARCH. VOL. 23. ISSUE 7. P. 1597 -1607 | 11 | 46% | 13 |
| 5 | KWON, MH , LEE, CJ , CHO, YY , KANG, HE , (2013) PHARMACOKINETICS OF A CYTOCHROME P450 2E1 PROBE, CHLORZOXAZONE, AND ITS 6-HYDROXY METABOLITE IN POLOXAMER 407-INDUCED HYPERLIPIDEMIC RATS.JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES. VOL. 16. ISSUE 4. P. 648-656 | 10 | 40% | 1 |
| 6 | CHAUDHARY, HR , BROCKS, DR , (2013) THE SINGLE DOSE POLOXAMER 407 MODEL OF HYPERLIPIDEMIA; SYSTEMIC EFFECTS ON LIPIDS ASSESSED USING PHARMACOKINETIC METHODS, AND ITS EFFECTS ON ADIPOKINES.JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES. VOL. 16. ISSUE 1. P. 65-73 | 10 | 37% | 7 |
| 7 | KHALIL, HA , BELAL, TS , EL-YAZBI, AF , HAMDY, DA , (2016) THE EFFECT OF INCREASED LIPOPROTEINS LEVELS ON THE DISPOSITION OF VINCRISTINE IN RAT.LIPIDS IN HEALTH AND DISEASE. VOL. 15. ISSUE . P. - | 9 | 38% | 0 |
| 8 | JOHNSTON, TP , (2010) POLOXAMER 407 AS A GENERAL LIPASE INHIBITOR: ITS IMPLICATIONS IN LIPID METABOLISM AND ATHEROMA FORMATION IN C57BL/6 MICE.JOURNAL OF PHARMACY AND PHARMACOLOGY. VOL. 62. ISSUE 12. P. 1807-1812 | 10 | 37% | 9 |
| 9 | JOHNSTON, TP , LI, YA , JAMAL, AS , STECHSCHULTE, DJ , DILEEPAN, KN , (2003) POLOXAMER 407-INDUCED ATHEROSCLEROSIS IN MICE APPEARS TO BE DUE TO LIPID DERANGEMENTS AND NOT DUE TO ITS DIRECT EFFECTS ON ENDOTHELIAL CELLS AND MACROPHAGES.MEDIATORS OF INFLAMMATION. VOL. 12. ISSUE 3. P. 147-155 | 11 | 33% | 13 |
| 10 | LOGINOVA, VM , TUZIKOV, FV , TUZIKOVA, NA , KOROLENKO, TA , (2013) COMPARATIVE CHARACTERISTICS OF LIPEMIA MODELS INDUCED BY INJECTIONS OF TRITON WR-1339 AND POLOXAMER 407 IN MICE.BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE. VOL. 155. ISSUE 2. P. 284-287 | 5 | 56% | 2 |
Classes with closest relation at Level 1 |